de Ridder L - Search Results

1

Benefits and risks of combining anti-tumor necrosis factor with immunomodulator therapy in pediatric inflammatory bowel disease.

Cozijnsen MA, Escher JC, Griffiths A, Turner D, de Ridder L. Cozijnsen MA, et al. Among authors: de ridder l. Inflamm Bowel Dis. 2015 Apr;21(4):951-61. doi: 10.1097/MIB.0000000000000245. Inflamm Bowel Dis. 2015. PMID: 25723615 Review.

2

[Infliximab therapy in children and adolescents with refractory Crohn's disease in the Netherlands; experience with 23 patients].

de Ridder L, Escher JC, Taminiau JA. de Ridder L, et al. Ned Tijdschr Geneeskd. 2002 Oct 5;146(40):1879-83. Ned Tijdschr Geneeskd. 2002. PMID: 12395595 Dutch.

3

Infliximab therapy in 30 patients with refractory pediatric crohn disease with and without fistulas in The Netherlands.

de Ridder L, Escher JC, Bouquet J, Schweizer JJ, Rings EH, Tolboom JJ, Houwen RH, Norbruis OF, Derkx BH, Taminiau JA. de Ridder L, et al. J Pediatr Gastroenterol Nutr. 2004 Jul;39(1):46-52. doi: 10.1097/00005176-200407000-00010. J Pediatr Gastroenterol Nutr. 2004. PMID: 15187780

4

Pharmacogenetics of thiopurine therapy in paediatric IBD patients.

De Ridder L, Van Dieren JM, Van Deventer HJ, Stokkers PC, Van der Woude JC, Van Vuuren AJ, Benninga MA, Escher JC, Hommes DW. De Ridder L, et al. Aliment Pharmacol Ther. 2006 Apr 15;23(8):1137-41. doi: 10.1111/j.1365-2036.2006.02853.x. Aliment Pharmacol Ther. 2006. PMID: 16611274 Free article.

5

Azathioprine maintains first remission in newly diagnosed pediatric Crohn's disease.

Jaspers GJ, Verkade HJ, Escher JC, de Ridder L, Taminiau JA, Rings EH. Jaspers GJ, et al. Among authors: de ridder l. Inflamm Bowel Dis. 2006 Sep;12(9):831-6. doi: 10.1097/01.mib.0000232470.00703.67. Inflamm Bowel Dis. 2006. PMID: 16954801

6

Genetic susceptibility has a more important role in pediatric-onset Crohn's disease than in adult-onset Crohn's disease.

de Ridder L, Weersma RK, Dijkstra G, van der Steege G, Benninga MA, Nolte IM, Taminiau JA, Hommes DW, Stokkers PC. de Ridder L, et al. Inflamm Bowel Dis. 2007 Sep;13(9):1083-92. doi: 10.1002/ibd.20171. Inflamm Bowel Dis. 2007. PMID: 17476680

7

Infliximab use in children and adolescents with inflammatory bowel disease.

de Ridder L, Benninga MA, Taminiau JA, Hommes DW, van Deventer SJ. de Ridder L, et al. J Pediatr Gastroenterol Nutr. 2007 Jul;45(1):3-14. doi: 10.1097/MPG.0b013e31803e171c. J Pediatr Gastroenterol Nutr. 2007. PMID: 17592358 Review.

8

Infliximab dependency in pediatric Crohn's disease: long-term follow-up of an unselected cohort.

de Ridder L, Rings EH, Damen GM, Kneepkens CM, Schweizer JJ, Kokke FT, Benninga MA, Norbruis OF, Hoekstra JH, Gijsbers CF, Escher JC. de Ridder L, et al. Inflamm Bowel Dis. 2008 Mar;14(3):353-8. doi: 10.1002/ibd.20329. Inflamm Bowel Dis. 2008. PMID: 18069674

9

Percutaneous endoscopic gastrostomy (PEG) in children is not a minor procedure: risk factors for major complications.

Vervloessem D, van Leersum F, Boer D, Hop WC, Escher JC, Madern GC, de Ridder L, Bax KN. Vervloessem D, et al. Among authors: de ridder l. Semin Pediatr Surg. 2009 May;18(2):93-7. doi: 10.1053/j.sempedsurg.2009.02.006. Semin Pediatr Surg. 2009. PMID: 19348998

10

[Guideline 'Diagnosis and treatment of inflammatory bowel disease in children'].

de Ridder L, Rings EH, Escher JC; CBO-werkgroep ‘IBD bij kinderen’. de Ridder L, et al. Ned Tijdschr Geneeskd. 2010;154:A1898. Ned Tijdschr Geneeskd. 2010. PMID: 21029495 Dutch.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

305 results

Search Page

Filters